Toronto, Ontario–(Newsfile Corp. – September 13, 2022) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) is providing a default status report in accordance...
Toronto, Ontario–(Newsfile Corp. – August 18, 2022) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) announces today that the Company anticipates being late...
Toronto, Ontario–(Newsfile Corp. – June 30, 2022) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) announced today that it has sold four patent...
Toronto, Ontario–(Newsfile Corp. – November 2, 2021) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) is providing a default status report in accordance...
Toronto, Ontario–(Newsfile Corp. – February 23, 2021) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) announced today the opening of the Aion International...
Toronto, Ontario–(Newsfile Corp. – February 3, 2021) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) announced today that it has granted and issued...
Toronto, Ontario–(Newsfile Corp. – October 30, 2020) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) announced today that the Company has entered into...
Neuroscientist, Healthcare Technology Entrepreneur to Lead Aion Through Important Next Phase Toronto, Ontario–(Newsfile Corp. – October 21, 2020) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic”...
Toronto, Ontario–(Newsfile Corp. – September 18, 2020) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) is pleased to announce the closing of a...
Dr. Fritsche has also been appointed Chief Science Officer of AI Pharma, a wholly-owned subsidiary of Aion Therapeutic Toronto, Ontario–(Newsfile Corp. – September 10, 2020) –...